Role of Cardiac Angiotensin II in Isoproterenol-Induced Left Ventricular Hypertrophy.

Hypertension - United States
doi 10.1161/01.hyp.19.6.708
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Isoproterenol-Induced Cardiac Hypertrophy: Role of Circulatory Versus Cardiac Renin-Angiotensin System

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2001English

Pivotal Role of a Gp91phox-Containing NADPH Oxidase in Angiotensin II-Induced Cardiac Hypertrophy in Mice

Circulation
Cardiovascular MedicinePhysiologyCardiology
2002English

Is Angiotensin II a Direct Mediator of Left Ventricular Hypertrophy?: Time for Another Look

Hypertension
Internal Medicine
2007English

New Take on the Role of Angiotensin II in Cardiac Hypertrophy and Fibrosis

Hypertension
Internal Medicine
2011English

Interleukin-6 Family of Cytokines Mediate Angiotensin II-induced Cardiac Hypertrophy in Rodent Cardiomyocytes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Regression of Isoproterenol-Induced Cardiac Hypertrophy by Na+/H+ Exchanger Inhibition

Hypertension
Internal Medicine
2003English

Role of EGF Receptor Activation in Angiotensin II-Induced Renal Epithelial Cell Hypertrophy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2006English

Influence of the Angiotensin II Antagonist Valsartan on Left Ventricular Hypertrophy in Patients With Essential Hypertension Response

Circulation
Cardiovascular MedicinePhysiologyCardiology
1999English

Evaluation of Anti-Hypertrophic Potential of Camellia Sinensis in Isoproterenol Induced Cardiac Hypertrophy

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy